Wednesday, October 8, 2025

Latest

Emerald Health Announces Exit From Cannabis Industry

And another one bites the dust. Emerald Health Therapeutics (CSE: EMH), one of the first players to enter the Canadian cannabis sector, this morning announced that it is getting out of both recreational and medical cannabis in Canada entirely.

The announcement comes just weeks after the firm revealed it has partnered with HYTN Cannabis to launch cannabis beverages in the country. Instead, the company has begun the process of soliciting purchasers for its Canadian cannabis assets, the proceeds of which will be used to strengthen the firms capital position.

The move is being made as the firm looks to cut back its monthly net cash burn. Instead, the firm will be pivoting to pharmaceutical development due to the expertise and experience in the field among its board members.

In making the announcement, Chairman Jim Heppell commented, “in a market with a very large number of cannabis operating licenses, increasing competition and declining retail prices, the path to achieving profitability and increasing shareholder value has been very challenging.”

The firms CEO, Riaz Bandali, will also be stepping down from his role with the company effective December 31.

Emerald Health last traded at $0.08 on the CSE.


Information for this briefing was found via Sedar and Emerald Health Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Emerald Health Sees Revenues Decline 32% To $2.9 Million In First Quarter 2020

Revenues continue to decline for Emerald Health Therapeutics (TSXV: EMH), with the firm posting first...

Friday, June 19, 2020, 08:00:00 AM

Emerald Health Announces Another Financing Below Market Rates, Dilutes Sciences Ownership

Emerald Health Therapeutics (TSXV: EMH) is raising money less than a month after it closed...

Monday, December 16, 2019, 09:04:02 AM

Emerald Health Looks To Delist From The TSX Venture

Emerald Health Therapeutics (TSXV: EMH) this morning announced that it is looking to delist from...

Tuesday, March 9, 2021, 07:33:21 AM

Emerald Health Posts Loss of $17.5 Million For Quarter, Conference Call Sees Investor Vent Frustrations with Management

Emerald Health Therapeutics (TSXV: EMH) released its third quarter financial statements late Friday night, revealing...

Monday, December 2, 2019, 01:04:25 PM

Village Farms Takes Majority Stake in Pure Sunfarms Venture

Village Farms (TSX: VFF) (NASDAQ: VFF) announced this morning that its equity increase in Pure...

Tuesday, November 26, 2019, 09:47:14 AM